With epiPancancer, detect up to 33 types of cancer early through our breakthrough blood test, leveraging DNA methylation patterns for unmatched precision

Enter your info if you are interested in learning more and someone will be in touch.

Thanks to the development of our epiPancancer, we can detect up to 33 different types of cancer. Current biomarkers lack sensitivity and specificity to detect cancer early. Available biomarkers and diagnostic methods are invasive and cannot be used for follow-up of a healthy population.

Our scientists conducted multiple cancer blood tests to investigate DNA methylation results from normal tissues, blood, and cancer from thousands of people and used proprietary methods to discover unique methylation profiles that are categorically different between each tissue type.  Our new Binary Categorical Differentiation (BCD) method identifies stark differences between cancer cells and normal cells.

  • epiPancancer Negative Report Template Download


There are no reviews yet.

Be the first to review “epiPancancer”

Your email address will not be published. Required fields are marked *

Scroll to Top